Our Research

Options for Delivering Isoniazid-Rifapentine (3HP)

Study Title: Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Trial)

Study Setting/Site: The Makerere University Joint AIDS Program (MJAP), Mulago ISS Clinic in Kampala, Uganda


This is a five-year project which started with a formative study in year one (November 2018)

Formative study objectives:

1.   To assess the costs (direct and indirect) faced by clients to attend clinic visits

2.   Conduct a pre-implementation assessment of 99DOTS using human-centered design (HCD) principles to refine the delivery strategy

3.   To tailor and pilot test a preliminary decision aid focused on helping clients choose between receiving 3HP via DOT and SAT (via Knowledge, Attitudes and Practices, KAP, Interviews)